Literature DB >> 27101571

Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.

Maria Moris1, David W Dawson, Jennifer Jiang, Jason Lewis, Aziza Nassar, Kenneth K Takeuchi, Anna R Lay, Qihui Zhai, Timothy R Donahue, Kimberly A Kelly, Howard C Crawford, Michael Wallace.   

Abstract

OBJECTIVE: This study aimed to evaluate Plectin-1 expression as a biomarker of malignant risk for intraductal papillary mucinous neoplasms (IPMNs).
METHODS: Plectin-1 immunohistochemistry (IHC) was performed retrospectively on surgical (n = 71) and cytological (n = 33) specimens from Mayo Clinic Jacksonville and UCLA Medical Center, including IPMNs with low-grade dysplasia, high-grade dysplasia (HGD), or an associated invasive adenocarcinoma.
RESULTS: Plectin-1 expression was increased in invasive adenocarcinoma compared with adjacent in situ IPMN (P = 0.005), as well as the in situ HGD component of IPMNs with invasive cancer compared with HGD of IPMNs without invasive cancer (P = 0.02). Plectin IHC discriminated IPMNs with invasive adenocarcinoma from noninvasive IPMN (area under the curve [AUC] of 0.79, 75% sensitivity, and 85% specificity) but was insufficient for discriminating HGD IPMN from low-grade dysplasia IPMNs in surgical resections (AUC of 0.67, 56% sensitivity, and 64% specificity) or fine-needle aspiration specimens (AUC of 0.45).
CONCLUSIONS: Although Plectin-1 IHC has insufficient accuracy to be used as a definitive biomarker for malignant risk in the evaluation of IPMN biopsy or cytological specimens, increased Plectin-1 expression observed in both invasive cancer and in situ HGD of malignant IPMNs suggests that it might be successfully leveraged as a cyst fluid biomarker or molecular imaging target.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27101571      PMCID: PMC5021548          DOI: 10.1097/MPA.0000000000000652

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  23 in total

Review 1.  Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis.

Authors:  Raghunandan Venkat; Barish H Edil; Richard D Schulick; Anne O Lidor; Martin A Makary; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2012-06       Impact factor: 12.969

2.  Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Jennifer Permuth-Wey; Dung-Tsa Chen; William J Fulp; Sean J Yoder; Yonghong Zhang; Christina Georgeades; Kazim Husain; Barbara Ann Centeno; Anthony M Magliocco; Domenico Coppola; Mokenge Malafa
Journal:  Cancer Prev Res (Phila)       Date:  2015-09

Review 3.  Early detection of sporadic pancreatic cancer: summative review.

Authors:  Suresh T Chari; Kimberly Kelly; Michael A Hollingsworth; Sarah P Thayer; David A Ahlquist; Dana K Andersen; Surinder K Batra; Teresa A Brentnall; Marcia Canto; Deborah F Cleeter; Matthew A Firpo; Sanjiv Sam Gambhir; Vay Liang W Go; O Joe Hines; Barbara J Kenner; David S Klimstra; Markus M Lerch; Michael J Levy; Anirban Maitra; Sean J Mulvihill; Gloria M Petersen; Andrew D Rhim; Diane M Simeone; Sudhir Srivastava; Masao Tanaka; Aaron I Vinik; David Wong
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327

4.  Comparison of preoperative conference-based diagnosis with histology of cystic tumors of the pancreas.

Authors:  Marco Del Chiaro; Ralf Segersvärd; Raffaella Pozzi Mucelli; Elena Rangelova; Nikolaos Kartalis; Christoph Ansorge; Urban Arnelo; John Blomberg; Matthias Löhr; Caroline Verbeke
Journal:  Ann Surg Oncol       Date:  2014-01-03       Impact factor: 5.344

5.  Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture.

Authors:  K Andrä; H Lassmann; R Bittner; S Shorny; R Fässler; F Propst; G Wiche
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

6.  A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Authors:  Simeon Springer; Yuxuan Wang; Marco Dal Molin; David L Masica; Yuchen Jiao; Isaac Kinde; Amanda Blackford; Siva P Raman; Christopher L Wolfgang; Tyler Tomita; Noushin Niknafs; Christopher Douville; Janine Ptak; Lisa Dobbyn; Peter J Allen; David S Klimstra; Mark A Schattner; C Max Schmidt; Michele Yip-Schneider; Oscar W Cummings; Randall E Brand; Herbert J Zeh; Aatur D Singhi; Aldo Scarpa; Roberto Salvia; Giuseppe Malleo; Giuseppe Zamboni; Massimo Falconi; Jin-Young Jang; Sun-Whe Kim; Wooil Kwon; Seung-Mo Hong; Ki-Byung Song; Song Cheol Kim; Niall Swan; Jean Murphy; Justin Geoghegan; William Brugge; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Richard Schulick; Barish H Edil; Volkan Adsay; Jorge Paulino; Jeanin van Hooft; Shinichi Yachida; Satoshi Nara; Nobuyoshi Hiraoka; Kenji Yamao; Susuma Hijioka; Schalk van der Merwe; Michael Goggins; Marcia Irene Canto; Nita Ahuja; Kenzo Hirose; Martin Makary; Matthew J Weiss; John Cameron; Meredith Pittman; James R Eshleman; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Rachel Karchin; Ralph H Hruban; Bert Vogelstein; Anne Marie Lennon
Journal:  Gastroenterology       Date:  2015-08-04       Impact factor: 22.682

Review 7.  Plakins in development and disease.

Authors:  Arnoud Sonnenberg; Ronald K H Liem
Journal:  Exp Cell Res       Date:  2007-04-19       Impact factor: 3.905

8.  Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.

Authors:  Kwang Hyuck Lee; Se-Joon Lee; Jong Kyun Lee; Ji Kon Ryu; Eun Young Kim; Tae Hyeon Kim; Jong Ho Moon; Woo Jin Lee; Yu Kyung Cho; Jae J Kim
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

9.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer.

Authors:  Soo J Shin; Jeffrey A Smith; Günther A Rezniczek; Sheng Pan; Ru Chen; Teresa A Brentnall; Gerhard Wiche; Kimberly A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

View more
  6 in total

1.  [99mTc]Tc-Labeled Plectin-Targeting Peptide as a Novel SPECT Probe for Tumor Imaging.

Authors:  Jiali Gong; Lingzhou Zhao; Jiqin Yang; Meilin Zhu; Jinhua Zhao
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

2.  Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer.

Authors:  Krishnendu Pal; Farah Al-Suraih; Roberto Gonzalez-Rodriguez; Shamit Kumar Dutta; Enfeng Wang; H Shaun Kwak; Thomas R Caulfield; Jeffery L Coffer; Santanu Bhattacharya
Journal:  Nanoscale       Date:  2017-10-19       Impact factor: 7.790

3.  NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition.

Authors:  Alexandra M Moore; Lei Zhou; Jing Cui; Luyi Li; Nanping Wu; Alice Yu; Soumya Poddar; Keke Liang; Evan R Abt; Stephanie Kim; Razmik Ghukasyan; Nooneh Khachatourian; Kristina Pagano; Irmina Elliott; Amanda M Dann; Rana Riahi; Thuc Le; David W Dawson; Caius G Radu; Timothy R Donahue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

Review 4.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

Review 5.  Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions.

Authors:  Dominika Wietrzykowska-Grishanovich; Ewa Pawlik; Katarzyna Neubauer
Journal:  Medicina (Kaunas)       Date:  2022-07-26       Impact factor: 2.948

6.  Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm.

Authors:  Ye Rim Chang; Taesung Park; Sung Hyo Park; Yong Kang Kim; Kyoung Bun Lee; Sun-Whe Kim; Jin-Young Jang
Journal:  Oncotarget       Date:  2017-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.